Close
Close

Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD

Descriptive Information
Brief Title † Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD
Official Title † Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD
Brief Summary Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy with approximately 500 patients in Denmark. It is characterized by weakness and wasting of the facial muscles, the muscles in the shoulder region and of the legs. The primary aim of this study is to investigate possible links and order between inflammation and fat infiltration in the muscles in patients with FSHD. Approximately 15 patients with FSHD will be recruited for repeated MRI-scans during a year where the inflammation and fat infiltration in the muscles can be quantified.
Detailed Description
Study Phase N/A
Study Type † Observational
Study Design †
Primary Outcome Measure † Muscle inflammation
Secondary Outcome Measure † Muscle strength
Condition † Facioscapulohumeral Muscular Dystrophy 1a
Intervention † OtherNo intervention, observational
Study Arms / Comparison Groups Patient group Patients over 18 years old with confirmed FSHD (facioscapulohumeral muscular dystrophy).
Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status † Other
Estimated Enrollment † 15
Start Date † February 2016
Completion Date December 2017
Primary Completion Date October 2017
Eligibility Criteria † Inclusion Criteria: - Confirmed FSHD Exclusion Criteria: - All contraindications for undergoing an MRI scan
Gender All
Ages 18 Years - N/A
Accepts Healthy Volunteers No
Contacts †† Julia R Dahlqvist, MD, 004535456126, julia.rebecka.dahlqvist@regionh.dk
Location Countries † Denmark
Administrative Information
NCT ID † NCT02541292
Organization ID H-15009760
Secondary IDs ††
Responsible Party Principal Investigator
Study Sponsor † Rigshospitalet, Denmark
Collaborators ††
Investigators † : ,
Information Provided By
Verification Date April 2017
First Received Date † September 2, 2015
Last Updated Date April 10, 2017
† Required WHO trial registration data element.
†† WHO trial registration data element that is required only if it exists.
Find a Clinical Trial
Trending videos
by Abidemi Uruejoma
29,191 views
by Christine DuBois
23,757 views
by Abidemi Uruejoma
21,583 views
Free Newsletter